Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5697461 | Bulletin du Cancer | 2016 | 12 Pages |
Abstract
Two years after treatment, rates of persisting UI and/or SD remain high. Treatment by prostatectomy was significantly associated with an increased risk of persisting adverse effects at two years. The different toxicities between treatments should be presented to patients before initiating therapy in order to encourage the patient to contributed to shared treatment decision-making.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Faïza Bessaoud, Mattéa Orsini, François Iborra, Xavier Rebillard, Antoine Faix, Maryvonne Soulier, Jean-Pierre Daurès, Brigitte Trétarre,